BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2506447)

  • 1. Protease nexin I, a serpin, inhibits plasminogen-dependent degradation of muscle extracellular matrix.
    Rao JS; Kahler CB; Baker JB; Festoff BW
    Muscle Nerve; 1989 Aug; 12(8):640-6. PubMed ID: 2506447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activators and inhibitors in the neuromuscular system: III. The serpin protease nexin I is synthesized by muscle and localized at neuromuscular synapses.
    Festoff BW; Rao JS; Hantaï D
    J Cell Physiol; 1991 Apr; 147(1):76-86. PubMed ID: 2037625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activators and their inhibitors in the neuromuscular system: II. Serpins and serpin: protease complex receptors increase during in vitro myogenesis.
    Festoff BW; Rao JS; Rayford A; Hantaï D
    J Cell Physiol; 1990 Aug; 144(2):272-9. PubMed ID: 2166058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin.
    Rao JS; Baker JB; Morantz RA; Kimler B; Evans R; Festoff BW
    Cancer Res; 1990 Aug; 50(16):5039-44. PubMed ID: 2116223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine proteases and serpins: their possible roles in the motor system.
    Hantaï D; Rao JS; Festoff BW
    Rev Neurol (Paris); 1988; 144(11):680-7. PubMed ID: 3148184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
    Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
    Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serine proteases and their inhibitors: their role in the differentiation in neuromuscular system].
    Hantaï D; Akaaboune M; Verdière-Sahuqué M; Lachkar S; Festoff BW
    C R Seances Soc Biol Fil; 1994; 188(5-6):541-52. PubMed ID: 7780796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator and serine protease inhibitor-E2 (protease nexin-1) expression by bovine granulosa cells in vitro.
    Cao M; Sahmi M; Lussier JG; Price CA
    Biol Reprod; 2004 Sep; 71(3):887-93. PubMed ID: 15128599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that a variety of cultured cells secrete protease nexin and produce a distinct cytoplasmic serine protease-binding factor.
    Eaton DL; Baker JB
    J Cell Physiol; 1983 Nov; 117(2):175-82. PubMed ID: 6579053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of protease nexin-1 on the fibroblast extracellular matrix.
    Farrell DH; Wagner SL; Yuan RH; Cunningham DD
    J Cell Physiol; 1988 Feb; 134(2):179-88. PubMed ID: 3279057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
    Webber MM; Waghray A
    Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of serpins and their cognate proteases in muscle after crush injury.
    Festoff BW; Reddy RB; VanBecelaere M; Smirnova I; Chao J
    J Cell Physiol; 1994 Apr; 159(1):11-8. PubMed ID: 8138578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors.
    Mbebi C; Hantaï D; Jandrot-Perrus M; Doyennette MA; Verdière-Sahuqué M
    J Cell Physiol; 1999 Jun; 179(3):305-14. PubMed ID: 10228949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by bovine endothelial cells of degradation by HT-1080 fibrosarcoma cells of extracellular matrix proteins.
    Heisel M; Laug WE; Jones PA
    J Natl Cancer Inst; 1983 Dec; 71(6):1183-7. PubMed ID: 6418940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells.
    Kasza A; Kowanetz M; Poślednik K; Witek B; Kordula T; Koj A
    Cytokine; 2001 Dec; 16(5):187-90. PubMed ID: 11814314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.
    Eaton DL; Baker JB
    J Cell Biol; 1983 Aug; 97(2):323-8. PubMed ID: 6224800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease nexin-1: a cellular serpin down-regulated by thrombin in rat aortic smooth muscle cells.
    Richard B; Arocas V; Guillin MC; Michel JB; Jandrot-Perrus M; Bouton MC
    J Cell Physiol; 2004 Oct; 201(1):138-45. PubMed ID: 15281096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
    Laug WE
    Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1.
    Kanse SM; Chavakis T; Al-Fakhri N; Hersemeyer K; Monard D; Preissner KT
    J Cell Sci; 2004 Jan; 117(Pt 3):477-85. PubMed ID: 14679304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.